72 results
DEFA14A
ABOS
Acumen Pharmaceuticals Inc
22 Apr 24
Additional proxy soliciting materials
4:31pm
of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. 3. To conduct
S-8
yfn3z23wv8mb75if432
27 Mar 24
Registration of securities for employees
4:02pm
S-8
EX-5.1
jj91h5xjjw tj
27 Mar 24
Registration of securities for employees
4:02pm
S-8
EX-23.2
kzxogr2p6cx
27 Mar 24
Registration of securities for employees
4:02pm
8-K
kvx23ecrqcxf
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
EX-99.1
5fuwlz d9yp578e0u6
19 Mar 24
Corporate Presentation March 2024 1
8:05am
8-K
EX-99.1
qnkgw7g0gu vg
12 Jan 24
Corporate Presentation January 2024 1
8:42am
8-K
EX-99.1
7xoalp7wh4
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
EX-99.1
hix826ua
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
424B5
xm7p2p2j9wpb
20 Jul 23
Prospectus supplement for primary offering
4:11pm